| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |